Antioxidant therapy in hemodialysis patients: a systematic review
- 1 February 2012
- journal article
- review article
- Published by Elsevier BV in Kidney International
- Vol. 81 (3), 233-246
- https://doi.org/10.1038/ki.2011.341
Abstract
No abstract availableThis publication has 80 references indexed in Scilit:
- Anti‐inflammatory effects of resveratrol: possible role in prevention of age‐related cardiovascular diseaseAnnals of the New York Academy of Sciences, 2011
- A Randomized, Controlled Trial of Early versus Late Initiation of DialysisThe New England Journal of Medicine, 2010
- Time course and dose response of alpha tocopherol on oxidative stress in haemodialysis patientsBMC Nephrology, 2009
- Antioxidants prevent health-promoting effects of physical exercise in humansProceedings of the National Academy of Sciences of the United States of America, 2009
- Rosuvastatin and Cardiovascular Events in Patients Undergoing HemodialysisThe New England Journal of Medicine, 2009
- Gamma-Tocopherol and Docosahexaenoic Acid Decrease Inflammation in Dialysis PatientsJournal of Renal Nutrition, 2007
- Serum Vitamin E and Oxidative Protein Modification in Hemodialysis: A Randomized Clinical TrialAmerican Journal of Kidney Diseases, 2007
- Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney diseaseKidney International, 2004
- The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremiaKidney International, 2002
- Advanced oxidation protein products as a novel marker of oxidative stress in uremiaKidney International, 1996